1785-S - Raw material for mRNA vaccine development
What the buyer wrote
CPI require a number of enzymes to use as part of its response to COVID-19 vaccine project. The Public Contract Regulations 2015 state in regulation 32.2) The negotiated procedure without prior publication may be used for public works contracts, public supply contracts and public service contracts in any of the following cases:- (ii)competition is absent for technical reasons Raw material for mRNA vaccine development/manufacture of a COVID 19 vaccine. This is a fast moving and time limited project. As a synthetically expressed mRNA vaccine, a DNA template is required for expression and manufacture. The DNA template design is the key IP and any transfer to 3rd party manufacturing sites needs…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- 1785-S - Raw material for mRNA vaccine development
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 18 Jun 2020
- Work ends
- 18 Dec 2020
- Kind of work
- Pharmacy and medicines
Who the buyer named
Rosanne Ryott was the named contact on this notice.